Metraipolis › archive › dc_c39d95997d91
Long-term adverse effects following COVID-19 vaccination: A comparative analysis of Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines — Europe PMC PMID:42675735
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42675735
- DOI
- 10.1097/md.0000000000050282
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T06:20:45.086Z
- SHA-256 of the archived text
0d8a0f50ba1c8d037f46a0feab4b25478402259a85b9a13e4766be36cb9e78ab- Stable URL of this page
https://metraipolis.com/documento/dc_c39d95997d91
How to cite
Long-term adverse effects following COVID-19 vaccination: A comparative analysis of Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines — Europe PMC PMID:42675735 — Europe PMC (en), https://europepmc.org/article/MED/42675735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c39d95997d91 (Metraipolis archive dc_c39d95997d91, sha256 0d8a0f50ba1c8d037f46a0feab4b25478402259a85b9a13e4766be36cb9e78ab)
BibTeX
@misc{dcc39d95997d91,
title = {Long-term adverse effects following COVID-19 vaccination: A comparative analysis of Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines — Europe PMC PMID:42675735},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42675735},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c39d95997d91; sha256 0d8a0f50ba1c8d037f46a0feab4b25478402259a85b9a13e4766be36cb9e78ab},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42675735. Agents can read the archived copy with the MCP tool read_document.